Recent News

By Category: Biosafety

NIAID Seeks Biodefense Priority Pathogen Therapeutics

The National Institute of Allergy and Infectious Diseases (NIAID) is seeking information regarding efforts to develop therapeutic products that demonstrate activity for the treatment of diseases on the NIAID Category A, B and C Priority Pathogens list.

Ebola 2014: Pandemic Preparedness Lessons Learned

In late July and early August many Americans were first learning about the Ebola threat to our nation and families—and we had a lot to learn. For those of us who had read Richard Preston’s Hot Zone (Anchor, 1995), the word Ebola produced frightening images of a deadly and contagious disease that caused organs to  Read More »

Genetic safety switches could help curb potential bioterror risks

The potential threat of bioterrorism using man-made biological organisms could be reduced, thanks to a new method developed by scientists.

Biological safety lock for genetically modified organisms

Scientists have genetically recoded a strain of E. coli to depend on a synthetic amino acid so the bacteria can’t survive outside the lab. The E. coli were also made resistant to two viruses.

Jan. 9 news: Measles at Disneyland, e-cigarette regulation, flu tracking